Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice

Nutr Res. 2017 Jul:43:69-81. doi: 10.1016/j.nutres.2017.05.007. Epub 2017 May 18.

Abstract

Nonalcoholic fatty liver disease is one of the most common complications of obesity. The Vitis vinifera L. grape skin extract (ACH09) is an important source of polyphenols, which are related to its antioxidant and antihyperglycemic activities. We hypothesized that ACH09 could also exert beneficial effects on metabolic disorders associated with obesity and evaluated ACH09's influence on high-fat (HF) diet-induced hepatic steatosis and insulin resistance in C57BL/6 mice. The animals were fed a standard diet (10% fat, control) or an HF diet (60% fat, HF) with or without ACH09 (200mg/[kg d]) for 12weeks. Our results showed that ACH09 reduced HF diet-induced body weight gain, prevented hepatic lipid accumulation and steatosis, and improved hyperglycemia and insulin resistance. The underlying mechanisms of these beneficial effects of ACH09 may involve the activation of hepatic insulin-signaling pathway because the expression of phosphorylated insulin receptor substrate-1, phosphatidylinositol 3-kinase, phosphorylated Akt serine/threonine kinase 1, and glucose transporter 2 was increased by ACH09 and correlated with improvement of hyperglycemia, hyperinsulinemia, and insulin resistance. ACH09 reduced the expression of the lipogenic factor sterol regulatory-element binding protein-1c in the liver and upregulated the lipolytic pathway (phosphorylated liver kinase B1/phosphorylated adenosine-monophosphate-activated protein kinase), which was associated with normal hepatic levels of triglyceride and cholesterol and prevention of steatosis. ACH09 prevented the hepatic oxidative damage in HF diet-fed mice probably by restoration of antioxidant activity. In conclusion, ACH09 protected mice from HF diet-induced obesity, insulin resistance, and hepatic steatosis. The regulation of hepatic insulin signaling pathway, lipogenesis, and oxidative stress may contribute to ACH09's protective effect.

Keywords: Grape skin, polyphenols; Hepatic steatosis; Insulin resistance, oxidative stress.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Cholesterol / blood
  • Cyclin-Dependent Kinase-Activating Kinase
  • Cyclin-Dependent Kinases / genetics
  • Cyclin-Dependent Kinases / metabolism
  • Diet, High-Fat / adverse effects*
  • Fatty Liver / drug therapy
  • Fatty Liver / prevention & control*
  • Glucose Transporter Type 2 / genetics
  • Glucose Transporter Type 2 / metabolism
  • Insulin / metabolism
  • Insulin Receptor Substrate Proteins / genetics
  • Insulin Receptor Substrate Proteins / metabolism
  • Insulin Resistance*
  • Lipogenesis / drug effects
  • Liver / drug effects*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity / drug therapy
  • Oxidative Stress / drug effects
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • Plant Extracts / pharmacology*
  • Polyphenols / pharmacology
  • Triglycerides / blood
  • Vitis / chemistry*

Substances

  • Antioxidants
  • Glucose Transporter Type 2
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • Plant Extracts
  • Polyphenols
  • Triglycerides
  • Cholesterol
  • Phosphatidylinositol 3-Kinases
  • Cyclin-Dependent Kinases
  • Cyclin-Dependent Kinase-Activating Kinase